Nuclease‐resistant 63‐bp trimeric siRNAs simultaneously silence three different genes in tumor cells

We designed a multimeric nuclease‐resistant 63‐bp trimeric small‐interfering RNA (tsiRNA) comprising in one duplex the sequence of siRNAs targeting mRNAs of MDR1, LMP2, and LMP7 genes. We show that such tsiRNA is able to suppress the expression of all the target genes independently and with high efficiency, acting via a Dicer‐dependent mechanism. tsiRNA is diced into 42‐ and 21‐bp duplexes inside the cell. tsiRNA‐induced gene silencing is characterized by kinetics similar to that of canonical siRNA, while the silencing efficiency is significantly higher than that of canonical siRNA with the same sequence.

[1]  V. Vlassov,et al.  Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells. , 2016, Biochimie.

[2]  K. Nakanishi.  Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins? , 2016, Wiley interdisciplinary reviews. RNA.

[3]  V. Vlassov,et al.  42‐ and 63‐bp anti‐MDR1‐siRNAs bearing 2′‐OMe modifications in nuclease‐sensitive sites induce specific and potent gene silencing , 2014, FEBS letters.

[4]  Xiangao Sun,et al.  Enhanced intracellular delivery and multi‐target gene silencing triggered by tripodal RNA structures , 2012, The journal of gene medicine.

[5]  William E. Salomon,et al.  Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC , 2010, Nucleic acids research.

[6]  V. Vlassov,et al.  Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect. , 2009, Oligonucleotides.

[7]  H. Soifer,et al.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. , 2008, Oligonucleotides.

[8]  A. Judge,et al.  2'-O-methyl-modified RNAs act as TLR7 antagonists. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  V. Hornung,et al.  siRNA and isRNA: two edges of one sword. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  M. Sioud,et al.  Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs , 2006, Journal of biomedicine & biotechnology.

[11]  Anastasia Khvorova,et al.  Induction of the interferon response by siRNA is cell type- and duplex length-dependent. , 2006, RNA.

[12]  D. Barford,et al.  Structural insights into mRNA recognition from a PIWI domain–siRNA guide complex , 2005, Nature.

[13]  Sangdun Choi,et al.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.

[14]  Michel Labouesse,et al.  RNA interference: genetic wand and genetic watchdog , 2000, Nature Cell Biology.

[15]  David C. Baulcombe,et al.  A species of small antisense RNA in posttranscriptional gene silencing in plants. , 1999, Science.

[16]  M. Godbole,et al.  Inexpensive SDS/phenol method for RNA extraction from tissues. , 1993, BioTechniques.

[17]  Hotaka Kobayashi,et al.  RISC assembly: Coordination between small RNAs and Argonaute proteins. , 2016, Biochimica et biophysica acta.

[18]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[19]  H. Vaucheret,et al.  Transcriptional gene silencing in plants: targets, inducers and regulators. , 2001, Trends in genetics : TIG.